Machine learning-based risk prediction model development for acute kidney injury in type 2 myocardial infarction patients
Source check: Source checked. Not independent scientific confirmation.
Finding: Methods analyze 1,378 MIMIC-IV type-2 myocardial-infarction ICU patients with a held-out 30% test set; Results report AKI incidence and model discrimination. Evidence is retrospective and bounded to this cohort.
Technology: The abstract reports a held-out acute-kidney-injury risk model for a defined myocardial-infarction cohort with measured test discrimination. The Methods specify the learned operation used for this case-specific result.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- The abstract reports a held-out acute-kidney-injury risk model for a defined myocardial-infarction cohort with measured test discrimination. The Methods specify the learned operation used for this case-specific result.
- Test and result
- Methods analyze 1,378 MIMIC-IV type-2 myocardial-infarction ICU patients with a held-out 30% test set; Results report AKI incidence and model discrimination. Evidence is retrospective and bounded to this cohort. The source reports the cohort or measured dataset, comparison/reference and evaluation used for this specific result; conclusions remain limited to that design.
- Limitation / still unknown
- limited to the reported cohort or experiment.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://doi.org/10.1038/s41598-025-29404-5 · https://www.nature.com/articles/s41598-025-29404-5
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.